267 related articles for article (PubMed ID: 32418324)
1. Imaging Mechanisms of Disease Progression in Multiple Sclerosis: Beyond Brain Atrophy.
Bagnato F; Gauthier SA; Laule C; Moore GRW; Bove R; Cai Z; Cohen-Adad J; Harrison DM; Klawiter EC; Morrow SA; Öz G; Rooney WD; Smith SA; Calabresi PA; Henry RG; Oh J; Ontaneda D; Pelletier D; Reich DS; Shinohara RT; Sicotte NL;
J Neuroimaging; 2020 May; 30(3):251-266. PubMed ID: 32418324
[TBL] [Abstract][Full Text] [Related]
2. Imaging as an Outcome Measure in Multiple Sclerosis.
Ontaneda D; Fox RJ
Neurotherapeutics; 2017 Jan; 14(1):24-34. PubMed ID: 27699722
[TBL] [Abstract][Full Text] [Related]
3. Imaging outcome measures of neuroprotection and repair in MS: A consensus statement from NAIMS.
Oh J; Ontaneda D; Azevedo C; Klawiter EC; Absinta M; Arnold DL; Bakshi R; Calabresi PA; Crainiceanu C; Dewey B; Freeman L; Gauthier S; Henry R; Inglese M; Kolind S; Li DKB; Mainero C; Menon RS; Nair G; Narayanan S; Nelson F; Pelletier D; Rauscher A; Rooney W; Sati P; Schwartz D; Shinohara RT; Tagge I; Traboulsee A; Wang Y; Yoo Y; Yousry T; Zhang Y; Robert Z; Sicotte NL; Reich DS;
Neurology; 2019 Mar; 92(11):519-533. PubMed ID: 30787160
[TBL] [Abstract][Full Text] [Related]
4. Spinal cord atrophy in anterior-posterior direction reflects impairment in multiple sclerosis.
Lundell H; Svolgaard O; Dogonowski AM; Romme Christensen J; Selleberg F; Soelberg Sørensen P; Blinkenberg M; Siebner HR; Garde E
Acta Neurol Scand; 2017 Oct; 136(4):330-337. PubMed ID: 28070886
[TBL] [Abstract][Full Text] [Related]
5. The Role of Advanced Magnetic Resonance Imaging Techniques in Multiple Sclerosis Clinical Trials.
Mahajan KR; Ontaneda D
Neurotherapeutics; 2017 Oct; 14(4):905-923. PubMed ID: 28770481
[TBL] [Abstract][Full Text] [Related]
6. Different patterns of longitudinal brain and spinal cord changes and their associations with disability progression in NMO and MS.
Liu Y; Duan Y; Huang J; Ren Z; Liu Z; Dong H; Weiler F; Hahn HK; Shi FD; Butzkueven H; Barkhof F; Li K
Eur Radiol; 2018 Jan; 28(1):96-103. PubMed ID: 28667482
[TBL] [Abstract][Full Text] [Related]
7. The role of MR volumetry in brain atrophy assessment in multiple sclerosis: A review of the literature.
Marciniewicz E; Podgórski P; Sąsiadek M; Bladowska J
Adv Clin Exp Med; 2019 Jul; 28(7):989-999. PubMed ID: 30729761
[TBL] [Abstract][Full Text] [Related]
8. Brain Atrophy in Multiple Sclerosis: Clinical Relevance and Technical Aspects.
Sastre-Garriga J; Pareto D; Rovira À
Neuroimaging Clin N Am; 2017 May; 27(2):289-300. PubMed ID: 28391787
[TBL] [Abstract][Full Text] [Related]
9. Measurement of brain and spinal cord atrophy by magnetic resonance imaging as a tool to monitor multiple sclerosis.
Bakshi R; Dandamudi VS; Neema M; De C; Bermel RA
J Neuroimaging; 2005; 15(4 Suppl):30S-45S. PubMed ID: 16385017
[TBL] [Abstract][Full Text] [Related]
10. MAGNIMS consensus recommendations on the use of brain and spinal cord atrophy measures in clinical practice.
Sastre-Garriga J; Pareto D; Battaglini M; Rocca MA; Ciccarelli O; Enzinger C; Wuerfel J; Sormani MP; Barkhof F; Yousry TA; De Stefano N; Tintoré M; Filippi M; Gasperini C; Kappos L; Río J; Frederiksen J; Palace J; Vrenken H; Montalban X; Rovira À;
Nat Rev Neurol; 2020 Mar; 16(3):171-182. PubMed ID: 32094485
[TBL] [Abstract][Full Text] [Related]
11. Pathogenesis of brain and spinal cord atrophy in multiple sclerosis.
Minagar A; Toledo EG; Alexander JS; Kelley RE
J Neuroimaging; 2004 Jul; 14(3 Suppl):5S-10S. PubMed ID: 15228754
[TBL] [Abstract][Full Text] [Related]
12. Spinal Cord Atrophy in Multiple Sclerosis: A Systematic Review and Meta-Analysis.
Casserly C; Seyman EE; Alcaide-Leon P; Guenette M; Lyons C; Sankar S; Svendrovski A; Baral S; Oh J
J Neuroimaging; 2018 Nov; 28(6):556-586. PubMed ID: 30102003
[TBL] [Abstract][Full Text] [Related]
13. Spinal cord atrophy as a primary outcome measure in phase II trials of progressive multiple sclerosis.
Cawley N; Tur C; Prados F; Plantone D; Kearney H; Abdel-Aziz K; Ourselin S; Wheeler-Kingshott CAG; Miller DH; Thompson AJ; Ciccarelli O
Mult Scler; 2018 Jun; 24(7):932-941. PubMed ID: 28516804
[TBL] [Abstract][Full Text] [Related]
14. What role should spinal cord MRI take in the future of multiple sclerosis surveillance?
Rocca MA; Preziosa P; Filippi M
Expert Rev Neurother; 2020 Aug; 20(8):783-797. PubMed ID: 32133874
[TBL] [Abstract][Full Text] [Related]
15. Spinal Cord in Multiple Sclerosis: Magnetic Resonance Imaging Features and Differential Diagnosis.
Rovira A; Auger C
Semin Ultrasound CT MR; 2016 Oct; 37(5):396-410. PubMed ID: 27616313
[TBL] [Abstract][Full Text] [Related]
16. MRI features associated with high likelihood of conversion of radiologically isolated syndrome to multiple sclerosis.
Bisulca J; De Lury A; Coyle PK; Syritsyna O; Peyster R; Bangiyev L; Duong TQ
Mult Scler Relat Disord; 2019 Nov; 36():101381. PubMed ID: 31518773
[TBL] [Abstract][Full Text] [Related]
17. A Novel Semiautomated Pipeline to Measure Brain Atrophy and Lesion Burden in Multiple Sclerosis: A Long-Term Comparative Study.
Uher T; Krasensky J; Vaneckova M; Sobisek L; Seidl Z; Havrdova E; Bergsland N; Dwyer MG; Horakova D; Zivadinov R
J Neuroimaging; 2017 Nov; 27(6):620-629. PubMed ID: 28464417
[TBL] [Abstract][Full Text] [Related]
18. Quantitative magnetic resonance imaging towards clinical application in multiple sclerosis.
Granziera C; Wuerfel J; Barkhof F; Calabrese M; De Stefano N; Enzinger C; Evangelou N; Filippi M; Geurts JJG; Reich DS; Rocca MA; Ropele S; Rovira À; Sati P; Toosy AT; Vrenken H; Gandini Wheeler-Kingshott CAM; Kappos L;
Brain; 2021 Jun; 144(5):1296-1311. PubMed ID: 33970206
[TBL] [Abstract][Full Text] [Related]
19. Spinal cord imaging in multiple sclerosis.
Tench CR; Morgan PS; Jaspan T; Auer DP; Constantinescu CS
J Neuroimaging; 2005; 15(4 Suppl):94S-102S. PubMed ID: 16385022
[TBL] [Abstract][Full Text] [Related]
20. Brain and spinal cord atrophy in multiple sclerosis: role as a surrogate measure of disease progression.
Simon JH
CNS Drugs; 2001; 15(6):427-36. PubMed ID: 11524021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
